Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Danaher Corporation
DHR
$227.56
Name : Danaher Corporation
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $160,095,469,568.00
EPSttm : 6.04
finviz dynamic chart for DHR
Danaher Corporation
$227.56
0.45%
$1.02
DHR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.31

Margin Of Safety %

2

Put/Call OI Ratio

0.64

EPS Next Q Diff

0.13

EPS Last/This Y

0.79

EPS This/Next Y

0.73

Price

227.56

Target Price

260.43

Analyst Recom

1.5

Performance Q

3.98

Upside

-40.9%

Beta

0.77

Ticker: DHR




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-21DHR234.090.571.0284105
2026-10-22DHR229.70.610.9386547
2026-10-23DHR230.430.611.0887702
2026-10-26DHR232.960.580.0877171
2026-10-27DHR232.030.531.2583105
2026-10-28DHR234.070.550.4885150
2026-10-29DHR236.990.550.3385681
2026-10-30DHR232.270.551.1686401
2026-11-02DHR228.070.561.5484174
2026-11-03DHR230.120.560.1884714
2026-11-04DHR235.130.560.3785412
2026-11-05DHR226.340.560.9486009
2026-11-06DHR230.30.570.4186309
2026-11-09DHR235.140.570.2985361
2026-11-10DHR236.180.561.3786400
2026-11-11DHR235.310.571.4987447
2026-11-12DHR232.150.590.4589631
2026-11-13DHR233.020.592.7389970
2026-11-16DHR230.10.630.4691165
2026-11-17DHR225.640.631.6192417
2026-11-18DHR228.420.640.3793392
2026-11-19DHR227.580.640.5794215
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-21DHR224.021.51435.68.51
2026-10-22DHR229.881.51223.88.51
2026-10-23DHR230.441.51336.08.51
2026-10-26DHR232.9915.21393.38.53
2026-10-27DHR232.0711.01308.78.58
2026-10-28DHR234.0111.01381.08.58
2026-10-29DHR236.9511.01402.18.59
2026-10-30DHR232.2811.01216.28.59
2026-11-02DHR228.1111.01228.68.59
2026-11-03DHR230.0811.01277.58.59
2026-11-04DHR234.9011.01451.08.59
2026-11-05DHR226.4011.01121.18.59
2026-11-06DHR230.2911.01431.48.59
2026-11-09DHR235.1011.01452.58.59
2026-11-10DHR236.1111.01355.38.59
2026-11-11DHR235.3011.01311.38.59
2026-11-12DHR232.1411.01253.18.59
2026-11-13DHR232.9511.01350.68.59
2026-11-16DHR230.1511.01253.68.59
2026-11-17DHR225.7011.01225.48.59
2026-11-18DHR228.4111.01398.38.59
2026-11-19DHR227.5611.01305.38.59
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-21DHR-0.09-0.821.40
2026-10-22DHR-0.09-0.821.40
2026-10-23DHR-0.09-0.821.40
2026-10-26DHR-0.09-1.081.40
2026-10-27DHR-0.09-1.081.27
2026-10-28DHR-0.09-1.081.27
2026-10-29DHR-0.09-1.081.27
2026-10-30DHR-0.15-1.081.27
2026-11-02DHR-0.15-1.051.27
2026-11-03DHR-0.15-1.051.27
2026-11-05DHR-0.15-1.051.27
2026-11-06DHR-0.15-1.051.27
2026-11-09DHR-0.15-1.211.27
2026-11-10DHR-0.15-1.211.27
2026-11-11DHR-0.18-1.211.31
2026-11-12DHR-0.18-1.211.31
2026-11-13DHR-0.18-1.211.31
2026-11-16DHR-0.18-0.591.31
2026-11-17DHR-0.18-0.591.31
2026-11-18DHR-0.18-0.591.31
2026-11-19DHR-0.18-0.591.31
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

2.11

Avg. EPS Est. Current Quarter

2.48

Avg. EPS Est. Next Quarter

2.24

Insider Transactions

-0.18

Institutional Transactions

-0.59

Beta

0.77

Average Sales Estimate Current Quarter

7492

Average Sales Estimate Next Quarter

6633

Fair Value

231.95

Quality Score

85

Growth Score

81

Sentiment Score

73

Actual DrawDown %

22.6

Max Drawdown 5-Year %

-43.3

Target Price

260.43

P/E

37.26

Forward P/E

24.44

PEG

2.57

P/S

6.25

P/B

2.99

P/Free Cash Flow

27.95

EPS

6.11

Average EPS Est. Cur. Y​

8.59

EPS Next Y. (Est.)

9.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.91

Relative Volume

1.01

Return on Equity vs Sector %

-18.5

Return on Equity vs Industry %

-3.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.08

EBIT Estimation

1305.3
◆ DHR Healthcare
$227.56
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
21/25
Volume
4/15
Valuation
15/20
TP/AR
2/10
Options
5/10
RSI
48.4
Range 1M
44.8%
Sup Dist
0.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
35 /100
WEAK
Momentum
4/25
Growth
15/30
Estimates
6/20
Inst/Vol
3/15
Options
7/10
EPS Yr
10.1%
EPS NY
8.5%
52W%
80.6%
💎
Long-Term Value
Quality companies, undervalued
34 /100
WEAK
🔴 SELL -1.5% upside
Quality
12/30
Valuation
3/30
Growth
12/25
Stability
7/10
LT Trend
0/5
Upside
-1.5%
Quality
85
MoS
2%
DHR — P/E HistoricalDiagnostics & Research
Danaher Corporation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 58000
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
DHR

Latest News

—
Caricamento notizie per DHR…
stock quote shares DHR – Danaher Corporation Stock Price stock today
news today DHR – Danaher Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch DHR – Danaher Corporation yahoo finance google finance
stock history DHR – Danaher Corporation invest stock market
stock prices DHR premarket after hours
ticker DHR fair value insiders trading